Newsbenzinga
Arvinas To Present Preliminary Phase 1 Data For ARV-393 In Relapsed/Refractory Non-Hodgkin Lymphoma At ASH Meeting December 14
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…